Preparation method of tetraazapyridine cyclophane impurity
Synthesis of 7-N-o-nitrophenyl-1,4,7,10-tetraazaz-2,6-pyridine rings through a specific four-step reaction process, solving the problem of difficult separation of isomer impurities and improving the Product purity and yield.
Patent Information
- Application Number
- CN202411008507.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-11-12
AI Technical Summary
During the synthesis of 1,4,7,10-tetraazaz-2,6-pyridine rings, isomer impurities with similar structures are easily generated, making it difficult to separate and purify, affecting subsequent research.
A specific four-step reaction process is adopted: diethylene triamine reacts with aldehyde ketone compounds to form the protective product of primary amine, which is then condensed with chlorine, hydrolyzed to obtain the protective product of medium amine, and is subjected to alkaline conditions with 2,6-bis (Chloromethyl)pyridine reaction to produce 7-N-o-nitrophenyl-1,4,7,10-tetraazaz-2,6-pyridine ring.
The generation of other isomers is avoided, the product purity and yield are improved, and the subsequent separation process is simplified.
Smart Images

Figure CN118930495A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of chemical pharmacy and relates to a method for preparing a drug impurity standard product, in particular to a method for preparing tetraazapyridine cyclophane impurities. Background Art
[0002] Tetrazopyridine cyclophane is a key intermediate in the synthesis of a variety of nuclear magnetic resonance imaging developers and diagnostic reagents (Tetrahedron, 2001, 57, 4713-4718), and has very important application value. Currently, it is mainly synthesized by the following methods:
[0003]
[0004] At present, impurities were found in the experimental preparation of 1,4,7,10-tetraaza-2,6-pyridine cyclophane using thioglycolic acid. The theoretical molecular weight of the target impurity is 391.45. The new compound prepared in the experiment was tested by LC-MS. Figure 2 As shown in the spectrum, [M+1]=392.7, the signal response is strong, and it is confirmed to be the target impurity. The related impurities may be isomers of each other due to their similar structures, so the possible impurities include:
[0005]
[0006] Formula V and Formula VI, Formula VII and Formula VIII are isomers and have similar physical and chemical properties, so it is difficult to separate and purify them, which causes certain difficulties for subsequent impurity research. Summary of the invention
[0007] In view of this, the object of the present invention is to provide a method for preparing 1,4,7,10-tetraaza-2,6-pyridine cyclophane impurities (Formula V) to solve the problems raised in the above background technology.
[0008] A method for preparing 1,4,7,10-tetraaza-2,6-pyridine cyclophane impurities, wherein the impurity is 7-N-o-nitrophenyl-1,4,7,10-tetraaza-2,6-pyridine cyclophane, and the preparation method is specifically as follows:
[0009] (A) using diethylenetriamine, a compound of formula I, as a raw material, and reacting it with an aldehyde or ketone compound in an alkaline aqueous solution to obtain a protected Schiff base of a primary amine (formula II);
[0010] (B) condensing a Schiff base with a chloride to obtain a protected product of a secondary amine (Formula III);
[0011] (C) hydrolyzing the compound of formula III to obtain the compound of formula IV;
[0012] (D) Formula IV reacts with 2,6-bis(chloromethyl)pyridine under alkaline conditions to obtain 7-N-o-nitrophenyl-1,4,7,10-tetraaza-2,6-pyridinecyclophane (Formula V). The above four-step reaction process is as follows:
[0013]
[0014] Furthermore, the alkaline aqueous solution includes one or more of a sodium carbonate aqueous solution, a sodium hydroxide aqueous solution, and a sodium bicarbonate aqueous solution, preferably a sodium carbonate aqueous solution.
[0015] Furthermore, the aldehyde and ketone compounds include one or more of ACE (acetone), MIBK (methyl isobutyl ketone), and MEK (methyl ethyl ketone), preferably MIBK.
[0016] Furthermore, the molar ratio of the compound of formula I to M IBK is 1:1.5-6, preferably 1:2.
[0017] Furthermore, the reaction method of step (A) is as follows: diethylenetriamine and M IBK are added to a reaction bottle, 20% sodium carbonate is used as a solvent, and after the reflux reaction is complete, extraction and concentration are performed to obtain a compound of formula II, i.e., a Schiff base of a protected product of a primary amine.
[0018] Furthermore, the molar ratio of the Schiff base to the chlorinated compound is 1:4-6, preferably 1:1.5, wherein the chlorinated compound is o-nitrobenzenesulfonyl chloride.
[0019] Furthermore, the reaction method of step (B) is as follows: the Schiff base of the compound of formula II and sodium bicarbonate are dissolved in acetonitrile, o-nitrobenzenesulfonyl chloride is added, the temperature is controlled at 50-60° C. and the reaction is carried out for 2-8 hours, and the compound of formula III, i.e., the protected product of the secondary amine, is obtained by concentration, pulping, filtration, and re-concentration.
[0020] Furthermore, the reaction method of step (C) is as follows: the compound of formula III uses water as a solvent, adds ammonia water, controls the temperature at 40-50° C. to react for 4-14 hours, and after the reaction is complete, extracts and concentrates to obtain the compound of formula IV.
[0021] Furthermore, the molar ratio of the compound of formula IV to 2,6-bis(chloromethyl)pyridine is 1:1.5 to 5.5, preferably 1:1.5.
[0022] Further, the base involved in the alkaline condition in step (D) is NaOH, NaHCO 3 、Na 2 CO 3 One or more of, preferably Na 2 CO 3 .
[0023] Further, the compound of formula IV and Na 2 CO3 The molar ratio is 1:4~7.5.
[0024] Furthermore, the reaction method of step (D) is as follows: the compound of formula IV and sodium carbonate are dissolved in acetonitrile, the temperature is raised to 70-80°C for reaction for 2h, and then an acetonitrile solution of 2,6-bis(chloromethyl)pyridine is added dropwise, and the temperature is kept for reaction for 4-14h. After filtering, beating and drying, 7-N-o-nitrophenyl-1,4,7,10-tetraaza-2,6-pyridine cyclophane (Formula V) is obtained.
[0025] Beneficial effects: When synthesizing 7-N-o-nitrophenyl-1,4,7,10-tetraaza-2,6-pyridine cyclophane, the present invention does not generate other isomers, does not require subsequent separation of the desired product, and improves the product yield. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 The HPLC chart of 7-N-o-nitrophenyl-1,4,7,10-tetraaza-2,6-pyridine cyclophanes prepared in the present invention.
[0027] Figure 2 This is the LCMS spectrum of the impurity produced when 1,4,7,10-tetraaza-2,6-pyridine cyclophane was prepared using thioglycolic acid. DETAILED DESCRIPTION
[0028] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific embodiments of the present invention are described in detail below in conjunction with the accompanying drawings. In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention can be implemented in many other ways different from those described below, and those skilled in the art can make similar improvements without violating the connotation of the present invention. Therefore, the present invention is not limited to the specific embodiments disclosed below.
[0029] Example 1
[0030] (A) Dissolve 5 g (48 mmol) of diethylenetriamine and 9.71 g of MI BK (96 mmol) in 50 ml of 20% sodium carbonate aqueous solution, heat and reflux for 4 h, monitor by TLC until the reaction of the raw materials is complete. Cool to room temperature, add 100 ml of DCM (dichloromethane) to the system and stir for 30 min, let stand for extraction and separation, collect the organic phase; use 3*100 ml of 20% Na 2 CO 3 Washing, anhydrous Na 2 SO 4 After drying and concentrating under reduced pressure, 10.36 g of Schiff base compound of formula II was obtained as a white needle-shaped solid with a yield of 80% and a purity of 98.37%. The synthetic route of step (A) is as follows:
[0031] (B) The white needle-like solid (38 mmol) obtained in step (A) was dissolved in 70 ml ACN (acetonitrile), and 6.5 g (2 mmol) of NaHCO was added. 3 , heat to 50-60℃ for 2h; then add acetonitrile solution of o-nitrosulfonyl chloride (12.89g (58mmol) dissolved in 50ml ACN), keep warm for 4h, monitor by TLC until the raw material reacts completely. Cool to room temperature, add salt and concentrate until there is no obvious fraction, add 300ml ACE (acetone) to the concentrate, stir at 30-40℃ for 2h, filter, collect the filtrate, and concentrate under reduced pressure to obtain 14.38g of the protection product of the secondary amine of formula III as a light yellow powder solid, with a yield of 82% and a purity of 97.34%. The synthetic route of step (B) is as follows:
[0032] (C) 14.38 g of the yellowish powder solid (32 mmol) obtained in step (B) was dissolved in 80 ml of water, 15 ml of concentrated aqueous ammonia was added dropwise at room temperature, and the mixture was stirred at 40-50°C for 6 h. TLC was monitored until the reaction of the raw material was complete. The reaction mixture was cooled to room temperature, 100 ml of DCM (dichloromethane) was added for extraction, and the organic phase was collected and washed with 3*100 ml of 20% NaCl and anhydrous Na 2 SO 4 After drying and concentrating under pressure, 7.78 g of a white solid compound of formula IV was obtained with a yield of 85% and a purity of 99.07%. The synthetic route of step (C) is as follows:
[0034] (D) The compound of formula IV (27 mmol) obtained in step (C) was dissolved in 70 ml of ACN (acetonitrile), and 14.3 g of Na 2 CO 3 The temperature was controlled at 70-80°C and stirred for 2h; 2,6-bis(chloromethyl)pyridine in acetonitrile solution (7.12g (40.5mmol) 2,6-bis(chloromethyl)pyridine dissolved in 70ml ACN) was added dropwise, and the reaction was kept warm for 8h. TLC was monitored until the reaction of the raw material was completed. The reaction was cooled to room temperature, filtered, and the filter cake was collected; 80ml of water was added to slurry at room temperature for 2h, filtered, and the wet product was slurried with 80ml ACE (acetone) for 1h, filtered, and dried to obtain 8.76g of compound V, with a yield of 83% and a purity of 99.03% (such as Figure 1 HPLC diagram), wherein the synthetic route of step (D) is as follows:
[0035] When synthesizing 7-N-o-nitrophenyl-1,4,7,10-tetraaza-2,6-pyridine cyclophane, the present invention does not generate other isomers, does not require subsequent separation of required products, and improves the product yield.
[0036] The present invention has been described through specific embodiments. Those skilled in the art can refer to the content of the present invention to appropriately change the raw materials, process conditions and other links to achieve corresponding other purposes. The relevant changes do not deviate from the content of the present invention. All similar replacements and modifications are obvious to those skilled in the art and are considered to be included in the scope of the present invention.
Claims
1. A method for preparing tetraazapyridine cyclophane impurities, characterized in that: The impurity is 7-N-o-nitrophenyl-1,4,7,10-tetraaza-2,6-pyridine cyclophane, and the synthesis route of the 7-N-o-nitrophenyl-1,4,7,10-tetraaza-2,6-pyridine cyclophane is as follows: The preparation method of the tetrazopyridine cyclophane impurities specifically comprises the following steps: (A) using diethylenetriamine, a compound of formula I, as a raw material, and reacting it with an aldehyde ketone compound in an alkaline aqueous solution to obtain a Schiff base of a compound of formula II; (B) reacting a compound of formula II with a chloro compound to obtain a compound of formula III, wherein the chloro compound is o-nitrobenzenesulfonyl chloride; (C) hydrolyzing the compound of formula III to obtain the compound of formula IV; (D) The compound of formula IV is condensed with 2,6-bis(chloromethyl)pyridine under alkaline conditions to obtain the compound of formula V.
2. A method for preparing tetraazapyridine cyclophane impurities according to claim 1, characterized in that: The aldehyde and ketone compounds include one or more of ACE (acetone), MIBK (methyl isobutyl ketone), and MEK (methyl ethyl ketone).
3. A method for preparing a tetraazapyridine cyclophane impurity according to claim 2, characterized in that: The aldehyde and ketone compound is MIBK, and the molar ratio of the compound of formula I to MIBK is 1:1.5-6.
4. A method for preparing tetraazapyridine cyclophane impurities according to claim 1, characterized in that: The alkaline aqueous solution in step (A) includes one or more of a sodium hydroxide aqueous solution, a sodium carbonate aqueous solution, and a sodium bicarbonate aqueous solution.
5. A method for preparing a tetraazapyridine cyclic phane impurity according to claim 1, characterized in that: The molar ratio of the Schiff base to the o-nitrobenzenesulfonyl chloride is 1:4-6.
6. A method for preparing tetraazapyridine cyclic phane impurities according to claim 1, characterized in that: The base involved in the alkaline condition in step (D) is one or more of NaOH, NaHCO3, and Na2CO3.
7. A method for preparing tetraazapyridine cyclophane impurities according to claim 6, characterized in that: The molar ratio of the compound of formula IV to Na2CO3 is 1:4-7.
5.
8. A method for preparing tetraazapyridine cyclic phane impurities according to claim 1, characterized in that: The molar ratio of the compound of formula IV to 2,6-bis(chloromethyl)pyridine is 1:1.5-5.5.
